Avanir Captures The Alamo; Acquisition Will Give Avanir FazaClo
Acquisition of the schizophrenia therapy FazaClo will complement Avanir’s Neurodex, which is under review at FDA.
Acquisition of the schizophrenia therapy FazaClo will complement Avanir’s Neurodex, which is under review at FDA.